University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Pierre Theodore, M.D.

Lung surgeon

Dr. Pierre Theodore is a surgeon who specializes in the lung, including minimally invasive surgery that shortens hospital stays, reduces pain and allows lung cancer patients to better tolerate chemotherapy, if required. He also is an experienced lung transplant surgeon. In his research, he is investigating lung transplants as treatment for lung cancer in patients with multifocal bronchioloalveolar carcinoma (BAC).

Theodore earned a medical degree at the University of Virginia School of Medicine. He completed a residency in general surgery and a cardiothoracic surgery fellowship at Johns Hopkins Hospital. He also completed fellowships in transplant biology fellowship at Harvard Medical School and in cardiothoracic surgery at La Pitie-Salpetriere Hospital, Paris, France. Theodore joined UCSF Medical Center in 2004 and was named as the first recipient of the Van Auken Endowed Chair in Thoracic Oncology in 2007. He is a member of the Stanley J. Sarnoff Endowment, American Association for the Advancement of Science, International Society for Heart Lung Transplant, Transplantation Society and Society of Thoracic Surgeons. Theodore, who served as a lieutenant commander in the U.S. Naval Reserve Medical Corps, is an assistant professor of surgery at UCSF.


Thoracic Surgery and Oncology
1600 Divisadero St., Fourth Floor
San Francisco, CA 94143-1705
Phone: (415) 885-3882
Fax: (415) 353-7151

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Pierre Theodore

Additional Languages



University of Virginia School of Medicine 1995


Johns Hopkins Hospital, General Surgery 2001


Johns Hopkins Hospital, Thoracic Surgery 2004

Selected Research and Publications

  1. Woodard GA, Gubens MA, Jahan TM, Jones KD, Kukreja J, Theodore PR, Cardozo S, Jew G, Clary-Macy C, Jablons DM, Mann MJ. Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer. Clin Lung Cancer. 2014 Nov; 15(6):426-32.
  2. Doyon JB, Sutton DA, Theodore P, Dhillon G, Jones KD, Thompson EH, Fu J, Wickes BL, Koehler JE, Schwartz BS. Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient. J Clin Microbiol. 2013 Feb; 51(2):719-22.
  3. Han SJ, Lau D, Lu DC, Theodore P, Chou D. Anterior thoracolumbar corpectomies: approach morbidity with and without an access surgeon. Neurosurgery. 2011 May; 68(5):1220-5; discussion 1225-6.
  4. Tonna J, Palefsky JM, Rabban J, Campos GM, Theodore P, Ladabaum U. Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51. Dis Esophagus. 2010 Jul; 23(5):E17-20.
  5. Wang YC, Iezza G, Zuraek MB, Jablons DM, Theodore PR, Bergsland EK, Donner DB, Warren RS, Nakakura EK. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. J Surg Res. 2010 Sep; 163(1):47-51.
  6. Campos GM, Jablons D, Brown LM, Ramirez RM, Rabl C, Theodore P. A safe and reproducible anastomotic technique for minimally invasive Ivor Lewis oesophagectomy: the circular-stapled anastomosis with the trans-oral anvil. Eur J Cardiothorac Surg. 2010 Jun; 37(6):1421-6.
  7. Mukhtar RA, Theodore PR. Benign thoracic disease in the elderly. Thorac Surg Clin. 2009 Aug; 19(3):313-9.
  8. Theodore PR. Emergent management of malignancy-related acute airway obstruction. Emerg Med Clin North Am. 2009 May; 27(2):231-41.
  9. Hirsch J, Niemann CU, Hansen KC, Choi S, Su X, Frank JA, Fang X, Hirose R, Theodore P, Sapru A, Burlingame AL, Matthay MA. Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion. Crit Care Med. 2008 Jun; 36(6):1846-54.
  10. Lu DC, Theodore P, Korn WM, Chou D. Esophageal erosion 9 years after anterior cervical plate implantation. Surg Neurol. 2008 Mar; 69(3):310-2; discussion 312-3.
  11. Gasper WJ, Jamshidi R, Theodore PR. Palliation of thoracic malignancies. Surg Oncol. 2007 Dec; 16(4):259-65.
  12. Sweet MP, Patti MG, Leard LE, Golden JA, Hays SR, Hoopes C, Theodore PR. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg. 2007 Apr; 133(4):1078-84.
  13. Vartanian SM, Colaco S, Orloff LE, Theodore PR. Oklahoma prosthesis: resection of tumor of clavicle and chest wall reconstructed with a custom composite graft. Ann Thorac Surg. 2006 Jul; 82(1):332-4.
  14. Vu L, Theodore PR. Localization of a corticotropin-secreting tumor by thoracoscopic pulmonary venous sampling. N Engl J Med. 2005 Aug 25; 353(8):851-2.
  15. Leprince P, Combes A, Bonnet N, Ouattara A, Luyt CE, Theodore P, Léger P, Pavie A. Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation. Eur J Cardiothorac Surg. 2003 Sep; 24(3):399-403.
  16. Le Guern AC, Giovino MA, Abe M, Theodore PR, Qi J, Down JD, Sachs DH, Sykes M, Yang YG. Stem cell activity of porcine c-kit+ hematopoietic cells. Exp Hematol. 2003 Sep; 31(9):833-40.
  17. Theodore PR, Simon AR, Warrens AN, Sackstein R, Sykes M. Porcine mononuclear cells adhere to human fibronectin independently of very late antigen-5: implications for donor-specific tolerance induction in xenotransplantation. Xenotransplantation. 2002 Jul; 9(4):277-89.
  18. Heinz M, Huang CA, Emery DW, Giovino MA, LeGuern A, Kurilla-Mahon B, Theodore P, Arn JS, Sykes M, Mulligan R, Down JD, Sachs DH, Goodell MA. Use of CD9 expression to enrich for porcine hematopoietic progenitors. Exp Hematol. 2002 Jul; 30(7):809-15.
  19. Warrens AN, Simon AR, Theodore PR, Sachs DH, Sykes M. Cross-species compatibility of intercellular adhesion molecule-1 (CD54) with its ligands. Transplantation. 2000 Feb 15; 69(3):394-9.
  20. Yang YG, Chen AM, Garrett LJ, Sergio JJ, Theodore P, Awwad M, VerHalen J, Bodine DM, Sachs DH, Sykes M. Development and analysis of transgenic mice expressing porcine hematopoietic cytokines: a model for achieving durable porcine hematopoietic chimerism across an extensive xenogeneic barrier. Xenotransplantation. 2000 Feb; 7(1):58-64.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.